Allopurinol‐induced severe cutaneous adverse drug reactions: Risk minimization measures in Malaysia-Reference-Cited by-同舟云学术

Allopurinol‐induced severe cutaneous adverse drug reactions: Risk minimization measures in Malaysia

Published:2020-10 Issue:10 Volume:29 Page:1254-1262
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Panickar Rema¹²,Wo Wee Kee¹,Ali Norleen M.¹,Tang Min Moon³,Ramanathan G. R. Letchuman⁴,Kamarulzaman Adeeba²,Aziz Zoriah²⁵^ORCID

Affiliation:

1. National Pharmaceutical Regulatory Agency Ministry of Health Petaling Jaya Malaysia

2. Faculty of Medicine University of Malaya Kuala Lumpur Malaysia

3. Department of Dermatology Hospital Kuala Lumpur, Ministry of Health Kuala Lumpur Malaysia

4. Department of Medicine Hospital Raja Permaisuri Bainun, Ministry of Health Ipoh Malaysia

5. Faculty of Pharmacy MAHSA University Selangor Malaysia

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5033

Reference43 articles.

1. Uric Acid

2. Risk of cutaneous adverse reactions associated with allopurinol or febuxostat in real‐world patients: a nationwide study;Lin CW;Int J Clin Pract,2019

3. Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia

4. Allopurinol hypersensitivity: investigating the cause and minimizing the risk

5. Clinical heterogeneity of drug hypersensitivity

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies to enhance risk communication about medicines in Malaysia: a Delphi study among multinational experts;BMC Health Services Research;2024-09-03

2. Allopurinol induced severe cutaneous adverse reactions: Vigilance of prescription (31 cases);Revue Française d'Allergologie;2023-03

3. DNA methylation of ITGB2 contributes to allopurinol hypersensitivity;Clinical Immunology;2023-03

4. Enhancing medication risk communication in developing countries: a cross-sectional survey among doctors and pharmacists in Malaysia;BMC Public Health;2022-07-05

5. Incidence of allopurinol‐induced severe cutaneous adverse drug reaction in Malaysia;British Journal of Clinical Pharmacology;2022-04-04